Abstract
The biotechnology market in Asia-Pacific region looks very lucrative from
investment perspective as it has enjoyed double-digit growth in past few
years. The industry is attracting more and more private investments in wake of
immense growth opportunities and vast untapped biotech markets. Identifying
the future growth potential of the industry, the governments of different
countries in the Asia-Pacific region are taking up various initiatives to
promote research in the region. Overall, the Asia-Pacific biotech market is
expected to spur future growth in the global biotechnology market.
According to our new research report, “Asia Pacific Biotechnology Market
(2008-2012)”, the Asia-Pacific biotech market is projected to grow at a
CAGR of around 14% during 2010-2012. Currently, the industry is driven by new
developing markets like Malaysia and India where developments in the sector
are on a full swing. Anticipating the future growth, governments are promoting
the industry by making investments and implementing new strategies.
Our research has found that Japan and China are dominating the industry. While
higher growth rate has been witnessed in emerging markets like Malaysia, Japan
and China are anticipated to dominate the market in future with combined share
of around 70% of overall market. In this regard, our report provides rational
analysis of various factors which will drive this market over the forecast
period.
The report also provides extensive information and data of the biotech market
in the Asia-Pacific region as well as discusses the emerging trends like
contract research and manufacturing, bioinformatics, generics market etc. It
provides valuable information to pharmaceutical & biotechnology companies and
investors looking to enter these markets and help them to devise strategies in
accordance to the individual markets. The report also contains detailed
analysis and statistics of the market size, growth, share, segmentation,
geographic distribution and trends in technology development.
|